Literature DB >> 8168827

Immunoglobulin allotypes in Ecuadorian Cayapa Indians.

M A Kron1, L Gately, J P Pandey, M H Jurado, J Rumbea Guzman.   

Abstract

Indigenous Indian groups comprise approximately 20% of Ecuador's population, the third largest percentage in all of Central or South America, yet immunogenetic data on these groups are lacking in the literature. In the course of population migration studies, sera collected from 65 Ecuadorians living in the northern province of Esmeraldas were typed for six GM and two KM markers. The study population consisted of 47 Cayapa Indians and 18 blacks of African origin, descendants of slaves imported into the area during the seventeenth century. The Cayapa demonstrated three GM phenotypes, two of which are common to other South American Indian tribes. The frequency of KM1 positive Cayapa Indians (63%) is similar to other South American Indian tribes, but is significantly greater than the Huaorani of eastern Ecuador (2%), the only other Ecuadorian Indian group for whom limited immunoglobulin allotype data are available (chi 2 = 35.8, P < 0.0001).

Mesh:

Substances:

Year:  1994        PMID: 8168827     DOI: 10.1007/bf00202815

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  15 in total

Review 1.  Gm and Km allotypes, immune response and disease susceptibility.

Authors:  S Whittingham; D N Propert
Journal:  Monogr Allergy       Date:  1986

2.  Genetic variation within a linguistic group: Apalai-Wayana and other Carib tribes.

Authors:  F M Salzano; F L Black; S M Callegari-Jacques; S E Santos; T A Weimer; M A Mestriner; J P Pandey; M H Hutz; T T Rieger
Journal:  Am J Phys Anthropol       Date:  1988-03       Impact factor: 2.868

3.  Onchocerciasis in Ecuador, 1980-1986: epidemiological evaluation of the disease in the Esmeraldas province.

Authors:  R H Guderian; B J Beck; J R Proano; C D Mackenzie
Journal:  Eur J Epidemiol       Date:  1989-09       Impact factor: 8.082

4.  Guidelines for human gene nomenclature. An international system for human gene nomenclature (ISGN, 1987).

Authors:  T B Shows; P J McAlpine; C Boucheix; F S Collins; P M Conneally; J Frézal; H Gershowitz; P N Goodfellow; J G Hall; P Issitt; C A Jones; B B Knowles; M Lewis; V A McKusick; M Meisler; N E Morton; P Rubenstein; M S Schanfield; R D Schmickel; M H Skolnick; M A Spence; G R Sutherland; M Traver; N Van Cong; H F Willard
Journal:  Cytogenet Cell Genet       Date:  1987

5.  Genetic variation within the Tupi linguistic group: new data on three Amazonian tribes.

Authors:  F L Black; S E Santos; F M Salzano; S M Callegari-Jacques; T A Weimer; M H Franco; M H Hutz; T T Rieger; R R Kubo; M A Mestriner
Journal:  Ann Hum Biol       Date:  1988 Sep-Oct       Impact factor: 1.533

6.  A new rapid method for genetic typing of human immunoglobulins.

Authors:  G N Vyas; H H Fudenberg; H M Pretty; E R Gold
Journal:  J Immunol       Date:  1968-02       Impact factor: 5.422

7.  Genetic control of survival in epidemics.

Authors:  R R de Vries; P Meera Khan; L F Bernini; E van Loghem; J J van Rood
Journal:  J Immunogenet       Date:  1979-08

8.  The immunoglobulin allotypes (Gm and Km) of twelve Indian tribes of Central and South America.

Authors:  H Gershowitz; J V Neel
Journal:  Am J Phys Anthropol       Date:  1978-09       Impact factor: 2.868

9.  Immunoglobulin allotypes and IgG subclass antibody response to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients.

Authors:  T Pressler; J P Pandey; F Espersen; S S Pedersen; A Fomsgaard; C Koch; N Høiby
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

10.  Onchodermatitis--correlation between skin disease and parasitic load in an endemic focus in Ecuador.

Authors:  R J Hay; C D Mackenzie; R Guderian; W C Noble; J R Proano; J F Williams
Journal:  Br J Dermatol       Date:  1989-08       Impact factor: 9.302

View more
  1 in total

1.  Immunoglobulin kappa chain allotypes (KM) in onchocerciasis.

Authors:  J P Pandey; L H Elson; S E Sutherland; R H Guderian; E Araujo; T B Nutman
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.